Literature DB >> 22117311

[Two cases of successfully treated intravascular lymphoma presenting with fever and dyspnea].

Ayako Sakurai1, Keisuke Tomii, Akane Haruna, Nobuyuki Katakami, Yutaka Takahashi, Yukihiro Imai.   

Abstract

We report two patients with intravascular large B-cell lymphoma who presented with fever and dyspnea. Serum level of lactate dehydrogenase (LDH) and soluble interleukin-2 receptor (sIL-2R) levels were extremely high in both cases. Chest CT revealed tumor mass and ground glass opacity in one patient, and no abnormality in another patient who had severe hypoxemia. Their perfusion ventilation lung scintigraphy demonstrated multiple defects, and gallium scintigraphy showed abnormal accumulation in both lungs, and the spleen. Both patients were successfully treated with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP). Initial chemotherapy was followed by high dose systemic chemotherapy with peripheral blood stem cell support. Intravascular large B-cell lymphoma should always be considered in the differential diagnosis of fever and hypoxemia with elevated serum LDH and sIL-2R, regardless of the chest CT findings.

Entities:  

Mesh:

Year:  2011        PMID: 22117311

Source DB:  PubMed          Journal:  Nihon Kokyuki Gakkai Zasshi        ISSN: 1343-3490


  3 in total

1.  Autologous hematopoietic stem cell transplantation for intravascular large B-cell lymphoma: the European Society for Blood and Marrow Transplantation experience.

Authors:  J Meissner; H Finel; S Dietrich; A Boumendil; E Kanfer; G Laboure; M Abecasis; J Cornelissen; J Delage; J Finke; U Hess; H Ludwig; M Mohty; T Pabst; P Pioltelli; S Robinson; P Samaras; S Montoto; P Dreger
Journal:  Bone Marrow Transplant       Date:  2016-12-19       Impact factor: 5.483

2.  A Case of Intravascular Diffuse Large B-Cell Lymphoma Initially Suspected as Interstitial Pneumonia Associated With Systemic Scleroderma.

Authors:  Tomoyo Oguri; Shinji Sasada; Yuki Aramaki-Sumii; Yumi Tsuchiya; Kota Ishioka; Saeko Takahashi; Hisako Kunieda; Yoshifumi Kimura; Reishi Seki; Shigemichi Hirose; Morio Nakamura
Journal:  J Investig Med High Impact Case Rep       Date:  2021 Jan-Dec

3.  Treatment strategy for reducing the risk of rituximab-induced cytokine release syndrome in patients with intravascular large B-cell lymphoma: a case report and review of the literature.

Authors:  Katsuhiro Makino; Jumi Nakata; Satoru Kawachi; Tatsuyuki Hayashi; Atsuo Nakajima; Munehiro Yokoyama
Journal:  J Med Case Rep       Date:  2013-12-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.